NODELMAN OLEG

CIK 00014543859 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001454385

Recent Transactions

50 trades

Conversion
Aktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−488,891→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−9,913,810→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Class A Common Stock
2026-01-12+965,190→ 965,190 total
Conversion
Aktis Oncology, Inc.$AKTS
Series B Redeemable Convertible Preferred Stock
2026-01-12−102,500→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Series B Redeemable Convertible Preferred Stock
2026-01-12−2,397,500→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−997,299→ 0 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+2,270,879→ 2,270,879 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+202,862→ 202,862 total
Conversion
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12+128,506→ 128,506 total
Purchase
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12$18.00/sh+2,077,779→ 4,348,658 total
Conversion
Aktis Oncology, Inc.$AKTS
Class A Common Stock
2026-01-12+86,222→ 86,222 total
Purchase
Aktis Oncology, Inc.$AKTS
Common Stock
2026-01-12$18.00/sh+144,443→ 347,305 total
Exercise of In-Money
Zymeworks Inc.$ZYME
Pre-Funded Warrants (right to acquire)
2025-06-26−5,086,521→ 0 total
Exercise of In-Money
Zymeworks Inc.$ZYME
Common Stock
2025-06-26$0.00/sh+5,086,480→ 22,970,388 total
Tax Payment
Zymeworks Inc.$ZYME
Common Stock
2025-06-26$12.71/sh−41→ 22,970,388 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-05-19$11.78/sh+5,919→ 17,883,908 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-05-15$11.43/sh+49,502→ 17,877,989 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-04-17$11.52/sh+54,760→ 17,828,487 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-04-16$11.16/sh+73,953→ 17,773,727 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-04-04$11.17/sh+196,438→ 17,699,774 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-04-03$11.84/sh+120,770→ 17,503,336 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-04-02$11.85/sh+74,360→ 17,382,566 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-04-01$11.60/sh+48,658→ 17,308,206 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-31$11.75/sh+4,397→ 17,259,548 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-26$12.24/sh+43,848→ 17,255,151 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-25$12.91/sh+53,501→ 17,211,303 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-24$13.08/sh+22,689→ 17,157,802 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-21$12.78/sh+31,033→ 17,135,113 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-20$12.93/sh+73,476→ 17,104,080 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-19$12.64/sh+58,306→ 17,030,604 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-18$12.65/sh+113,880→ 16,972,298 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-17$12.23/sh+56,277→ 16,858,418 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-13$12.48/sh+468,356→ 16,802,141 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-12$12.25/sh+292,934→ 16,333,785 total
Purchase
Zymeworks Inc.$ZYME
Common Stock
2025-03-11$11.49/sh+320,690→ 16,040,851 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2025-01-02$12.95/sh+6,646→ 7,880,094 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2024-12-31$12.93/sh+13,268→ 7,873,448 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2024-12-30$12.92/sh+65,184→ 7,860,180 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2023-09-21$1.36/sh+53,000→ 12,674,775 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2023-09-20$1.36/sh+117,100→ 12,621,775 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2023-09-19$1.26/sh+5,143,000→ 12,504,675 total
Disposition to Issuer
Panacea Acquisition Corp. II
Class A ordinary shares
2023-04-28−545,000→ 0 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2023-02-21$1.36/sh+53,000→ 12,674,775 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2023-02-20$1.36/sh+117,100→ 12,621,775 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2023-02-19$1.26/sh+5,143,000→ 12,504,675 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2022-05-05$21.63/sh+668,237→ 7,521,024 total
Sale
ANAPTYSBIO, INC$ANAB
Common Stock
2022-05-05$21.63/sh−668,237→ 7,521,024 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2021-11-24$7.69/sh+21,758→ 1,169,241 total
Purchase
Nuvation Bio Inc.$NUVB
Class A Common Stock
2021-11-24$7.69/sh+163,268→ 7,361,675 total
Award
Nuvation Bio Inc.$NUVB
Stock Option (Right to Buy)
2021-10-29+45,229→ 45,229 total

Companies

Recent Filings

Address

357 TEHAMA STREET #3

SAN FRANCISCO, CA, 94103

View on SEC.gov